PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Forty-three percent of melanoma patients have chronic complications from immunotherapies

2021-03-25
(Press-News.org) Chronic side effects among melanoma survivors after treatment with anti-PD-1 immunotherapies are more common than previously recognized, according to a study published March 25 in JAMA Oncology.

The chronic complications, which occurred in 43% of patients, affected the joints and endocrine system most commonly, and less often involved salivary glands, eyes, peripheral nerves and other organs. These complications may be long lasting, with only 14% of cases having been resolved at last follow-up. This finding contrasted with previously reported immunotherapy-related acute complications that affected visceral organs -- including the liver, colon, lungs and kidneys -- which were effectively treated with steroids. However, the vast majority of chronic complications were not severe or life threatening.

"Chronic and long-lasting side effects were more common than we expected and involved a variety of often overlooked organs like the thyroid, salivary glands and joints," said the study's senior author, Douglas Johnson, MD, MSCI, associate professor of Medicine at Vanderbilt University Medical Center and clinical director of Melanoma at Vanderbilt-Ingram Cancer Center.

The retrospective study reviewed the incidence and spectrum of chronic immune-related adverse events in melanoma patients who were treated with adjuvant anti-PD-1 immunotherapies (pembrolizumab or nivolumab) at eight academic medical centers between 2015 and 2020. Chronic complications were defined as those persisting at least 12 weeks after immunotherapy treatments had ended. The study is the first to systematically examine anti-PD-1-related chronic complications in patients with high-risk, resected melanoma.

Most of the chronic complications (96%) were grade 1 or 2 events with no or mild symptoms. The more common complications included adrenal insufficiency, arthritis, dermatitis and thyroiditis.

Rare and acute immune-related adverse events that occur early in the course of treatment with the immunotherapy, such as cardiovascular complications, can be more serious. Johnson and colleagues at Vanderbilt-Ingram first reported in 2016 rare but fatal cardiac side effects from immunotherapies.

"While these side effects are important to monitor and treat, anti-PD-1 therapies remain life saving for many patients with melanoma" Johnson said.

INFORMATION:

The study's lead author is J. Randall Patrinely, Jr., BA. Other contributing authors from Vanderbilt included Fei Ye, PhD; Ran Fan, PhD and Elizabeth Davis, MD.



ELSE PRESS RELEASES FROM THIS DATE:

Moderate daily caffeine intake during pregnancy may lead to smaller birth size

2021-03-25
Pregnant women who consumed the caffeine equivalent of as little as half a cup of coffee a day on average had slightly smaller babies than pregnant women who did not consume caffeinated beverages, according to a study by researchers at the National Institutes of Health. The researchers found corresponding reductions in size and lean body mass for infants whose mothers consumed below the 200 milligrams of caffeine per day--about two cups of coffee--believed to increase risks to the fetus. Smaller birth size can place infants at higher risk of obesity, heart ...

The CNIO describe how embryonic stem cells keep optimal conditions for use in regenerative medicine

The CNIO describe how embryonic stem cells keep optimal conditions for use in regenerative medicine
2021-03-25
Scientists at the Proteomics Core Unit of the Spanish National Cancer Research Centre (CNIO), headed by Javier Muñoz, have described the mechanisms, unknown to date, involved in maintaining embryonic stem cells in the best possible state for their use in regenerative medicine. Their results, published in Nature Communications, will help to find novel stem-cell therapies for brain stroke, heart disease or neurodegenerative conditions like Alzheimer's or Parkinson's disease. Naïve pluripotent stem cells, ideal for doing research Embryonic stem cells (ESCs) are pluripotent cells that can grow ...

Detecting hidden signals

2021-03-25
Quantum holds the promise of increasing the power of sensing technologies. While the field of quantum sensing has shown a lot of potential for detecting very small signals, the ability to truly optimize these sensors has been thwarted by the complexity of control schemes. In a paper published on March 25 in Nature Partner Journals - Quantum Information, a research team based at the Johns Hopkins University Applied Physics Laboratory (APL) in Laurel, Maryland, explained how they applied two theoretical tools of quantum information to these types of extremely sensitive signal detection tasks. Their research suggests that honing this sensitivity to detect signals while rejecting background noise will enable the use of quantum ...

Does selfishness evolve? Ask a cannibal

Does selfishness evolve? Ask a cannibal
2021-03-25
HOUSTON - (March 25, 2021) - One of nature's most prolific cannibals could be hiding in your pantry, and biologists have used it to show how social structure affects the evolution of selfish behavior. Researchers revealed that less selfish behavior evolved under living conditions that forced individuals to interact more frequently with siblings. While the finding was verified with insect experiments, Rice University biologist Volker Rudolf said the evolutionary principal could be applied to study any species, including humans. In a study published online this week in Ecology Letters, Rudolf, longtime collaborator Mike Boots of the University of California, Berkeley, and colleagues showed they could drive the evolution of cannibalism in ...

Global evidence for how EdTech can support pupils with disabilities is 'thinly spread'

2021-03-25
An 'astonishing' deficit of data about how the global boom in educational technology could help pupils with disabilities in low and middle-income countries has been highlighted in a new report. Despite widespread optimism that educational technology, or 'EdTech', can help to level the playing field for young people with disabilities, the study found a significant shortage of evidence about which innovations are best-positioned to help which children, and why; specifically in low-income contexts. The review also found that many teachers lack training on how to use new technology, or are reluctant to do so. The ...

Should you take fish oil? Depends on your genotype

2021-03-25
Fish oil supplements are a billion-dollar industry built on a foundation of purported, but not proven, health benefits. Now, new research from a team led by a University of Georgia scientist indicates that taking fish oil only provides health benefits if you have the right genetic makeup. The study, led by Kaixiong Ye and published in PLOS Genetics, focused on fish oil (and the omega-3 fatty acids it contains) and its effect on triglycerides, a type of fat in the blood and a biomarker for cardiovascular disease. "We've known for a few decades that a higher level of omega-3 fatty acids in the blood is associated with a lower risk of heart disease," said Ye, assistant professor ...

Common Alzheimer's treatment linked to slower cognitive decline

2021-03-25
Cholinesterase inhibitors are a group of drugs recommended for the treatment of Alzheimer's disease, but their effects on cognition have been debated and few studies have investigated their long-term effects. A new study involving researchers from Karolinska Institutet in Sweden and published in the journal Neurology shows persisting cognitive benefits and reduced mortality for up to five years after diagnosis. Alzheimer's disease is a cognitive brain disease that affects millions of patients around the world. Some 100,000 people in Sweden live with the diagnosis, which has a profound impact on the lives of both them and their families. Most of those who receive a diagnosis are over 65, but there are some patients ...

Will COVID-19 vaccines need to be adapted regularly?

Will COVID-19 vaccines need to be adapted regularly?
2021-03-25
Influenza vaccines need to be evaluated every year to ensure they remain effective against new influenza viruses. Will the same apply to COVID-19 vaccines? In order to gauge whether and to what extent this may be necessary, a team of researchers from Charité - Universitätsmedizin Berlin compared the evolution of endemic 'common cold' coronaviruses with that of influenza viruses. The researchers predict that, while the pandemic is ongoing, vaccines will need to undergo regular updates. A few years into the post-pandemic period, however, vaccines ...

Women accumulate Alzheimer's-related protein faster

2021-03-25
Alzheimer's disease seems to progress faster in women than in men. The protein tau accumulates at a higher rate in women, according to research from Lund University in Sweden. The study was recently published in Brain. Over 30 million people suffer from Alzheimer's disease worldwide, making it the most common form of dementia. Tau and beta-amyloid are two proteins known to aggregate and accumulate in the brain in patients with Alzheimer's. The first protein to aggregate in Alzheimer's is beta-amyloid. Men and women are equally affected by the first disease stages, and the analysis did not show any differences in the accumulation of ...

Massive study reveals few differences between men and women's brains

2021-03-25
How different are men and women's brains? The question has been explored for decades, but a new study led by Rosalind Franklin University neuroscientist END ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Forty-three percent of melanoma patients have chronic complications from immunotherapies